99 related articles for article (PubMed ID: 30036573)
1. Safety evaluation through genotoxicity and apoptotic markers following RISUG
Ansari AS; Badar A; Lohiya NK
Reprod Toxicol; 2018 Oct; 81():84-92. PubMed ID: 30036573
[TBL] [Abstract][Full Text] [Related]
2. Relative suitability of DMSO and NaHCO3 for reversal of RISUG® induced long-term contraception.
Ansari AS; Hussain M; Khan SR; Lohiya NK
Andrology; 2016 Mar; 4(2):306-13. PubMed ID: 26748683
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of genotoxicity in leukocytes and testis following intra-vasal contraception with RISUG and its reversal by DMSO and NaHCO₃ in Wistar albino rats.
Ansari AS; Alam I; Hussain M; Khan SR; Lohiya NK
Reprod Toxicol; 2013 Apr; 36():53-9. PubMed ID: 23246611
[TBL] [Abstract][Full Text] [Related]
4. Contraception with RISUG
Ansari AS; Badar A; Balasubramanian K; Lohiya NK
Asian J Androl; 2017; 19(4):389-395. PubMed ID: 27586026
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and Mutagenicity Evaluation Following RISUG Contraception Reversal in Rats.
Ansari AS; Hussain M; Khan SR; Badar A; Lohiya NK
Int J Toxicol; 2018 Nov; ():1091581818809473. PubMed ID: 30380967
[TBL] [Abstract][Full Text] [Related]
6. Sperm characteristics and teratology in rats following vas deferens occlusion with RISUG and its reversal.
Lohiya NK; Suthar R; Khandelwal A; Goyal S; Ansari AS; Manivannan B
Int J Androl; 2010 Feb; 33(1):e198-206. PubMed ID: 19811546
[TBL] [Abstract][Full Text] [Related]
7. Studies on biochemical, oxidative and genotoxicity alterations following vas blockage with reversible inhibition of sperm under guidance and reversal in rats.
Ansari AS; Hussain M; Khan SR; Badar A; Khilwani B; Lohiya NK
Indian J Pharmacol; 2022; 54(1):33-40. PubMed ID: 35343205
[TBL] [Abstract][Full Text] [Related]
8. RISUG (reversible inhibition of sperm under guidance)--an antimicrobial as male vas deferens implant for HIV free semen.
Guha SK
Med Hypotheses; 2005; 65(1):61-4. PubMed ID: 15893119
[TBL] [Abstract][Full Text] [Related]
9. Biophysical mechanism-mediated time-dependent effect on sperm of human and monkey vas implanted polyelectrolyte contraceptive.
Guha SK
Asian J Androl; 2007 Mar; 9(2):221-7. PubMed ID: 17334590
[TBL] [Abstract][Full Text] [Related]
10. Study of the micro-structural properties of RISUG--a newly developed male contraceptive.
Kumar S; Roy S; Chaudhury K; Sen P; Guha SK
J Biomed Mater Res B Appl Biomater; 2008 Jul; 86(1):154-61. PubMed ID: 18161821
[TBL] [Abstract][Full Text] [Related]
11. Studies on the membrane integrity of human sperm treated with a new injectable male contraceptive.
Chaudhury K; Bhattacharyya AK; Guha SK
Hum Reprod; 2004 Aug; 19(8):1826-30. PubMed ID: 15192063
[TBL] [Abstract][Full Text] [Related]
12. Perspectives of contraceptive choices for men.
Lohiya NK; Manivannan B; Bhande SS; Panneerdoss S; Garg S
Indian J Exp Biol; 2005 Nov; 43(11):1042-7. PubMed ID: 16313067
[TBL] [Abstract][Full Text] [Related]
13. Topological alterations in human spermatozoa associated with the polyelectrolytic effect of RISUG.
Kumar S; Chaudhury K; Sen P; Guha SK
Micron; 2006; 37(6):526-32. PubMed ID: 16504524
[TBL] [Abstract][Full Text] [Related]
14. A short-term evaluation of semen and accessory sex gland function in phase III trial subjects receiving intravasal contraceptive RISUG.
Chaki SP; Das HC; Misro MM
Contraception; 2003 Jan; 67(1):73-8. PubMed ID: 12521662
[TBL] [Abstract][Full Text] [Related]
15. Safety & efficacy of an intravasal, one-time injectable & non-hormonal male contraceptive (RISUG): A clinical experience.
Sharma RS; Mathur AK; Singh R; Das HC; Singh GJ; Toor DPS; Guha SK
Indian J Med Res; 2019 Jul; 150(1):81-86. PubMed ID: 31571633
[TBL] [Abstract][Full Text] [Related]
16. Smart RISUG: a potential new contraceptive and its magnetic field-mediated sperm interaction.
Jha RK; Jha PK; Guha SK
Int J Nanomedicine; 2009; 4():55-64. PubMed ID: 19421370
[TBL] [Abstract][Full Text] [Related]
17. RISUG
Khilwani B; Badar A; Ansari AS; Lohiya NK
Basic Clin Androl; 2020; 30():2. PubMed ID: 32082579
[TBL] [Abstract][Full Text] [Related]
18. RISUG: an intravasal injectable male contraceptive.
Lohiya NK; Alam I; Hussain M; Khan SR; Ansari AS
Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S63-72. PubMed ID: 25673546
[TBL] [Abstract][Full Text] [Related]
19. A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites.
Sharma U; Chaudhury K; Jagannathan NR; Guha SK
Reproduction; 2001 Sep; 122(3):431-6. PubMed ID: 11597307
[TBL] [Abstract][Full Text] [Related]
20. RISUG: a potential candidate for the entry inhibitor group of antiretroviral drugs.
Banerjee S; Guha SK
Med Hypotheses; 2009 Aug; 73(2):150-2. PubMed ID: 19409721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
